We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
38 result(s) found, displaying 11 to 20
-
-
Prescription medicine registrationActive ingredients: lemborexant.
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Perampanel hemisesquihydrate
-
Designation or determinationPriority review
-
Prescription medicine registrationActive ingredients: perampanel hemisesquihydrate.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for INOVELON rufinamide 100 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for INOVELON rufinamide 400 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for INOVELON rufinamide 200 mg film-coated tablet blister pack.
-
Designation or determinationProvisional approval
-
Designation or determinationOrphan drug